( mark information that enhances our abil...)State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report,Health

mark information that enhances our ability to analyze our employees' health care needs and the most efficient means to address those needs. It can also be used for developing and supporting multi-stakeholder efforts to support people with diabetes both locally, across Pennsylvania and West Virginia," said Alberto Colombi, MD, Medical Director, PPG Industries.

According to the Centers for Disease Control, more than 17 million Americans have diabetes, with an average of 1 million new cases being diagnosed each year in people over the age of 20. Nine out of ten of these patients have the Type 2 variety. The cost of diabetes in the US was approximately $132 billion in 2002, with $92 billion spent on medical services. The economic loss to the US economy due to higher rates of lost work time, disability and premature mortality associated with diabetes in the working population was approximately $40 billion in 2002.

About the Pittsburgh Type 2 Diabetes Report for 2006

The Pittsburgh Type 2 Diabetes Report for 2006 helps PBGH fulfill its commitment to its employer members and community health partners to promote and maintain a high quality, efficient and affordable health care delivery system. The report was produced with assistance from sanofi-aventis U.S. LLC. The complete report is available in electronic format on PBGH's website at http://www.pbghpa.com and may be downloaded free of charge.

About Pittsburgh Business Group on Health

Founded in 1981, the Pittsburgh Business Group on Health (PBGH) is a regional employer leadership organization representing 64 member organizations, more than 800,000 employees, dependents and retirees, and over $3 billion in health care expenditures. The coalition promotes education, collaboration, and innovation among its members to drive value and quality in health care and benefits. Programs and activities include raising awareness through community f
'"/>

Page: 1 2 3 4
Related medicine technology :

1. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
2. Obama Statement on Bush Veto of Stem Cell Bill
3. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
4. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
5. Vaxiion Researchers Discover Novel Vaccine Delivery System in Collaboration with San Diego State University
6. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
9. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
10. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference